Abstract
Introduction

52
While consensus has been achieved on many of the defining characteristics of healthy diets, 53 debate about the optimal macronutrient composition (e.g., fat vs. carbohydrates) for 54 cardiovascular health persists (29, 34) . Although lower fat diets were recommended through 2000 55 (12), these recommendations shifted to moderate fat, lower in carbohydrate diets, particularly 56 refined carbohydrate, thereafter (14). Higher fat diets, particularly higher in unsaturated fat, are 57 thought to be cardio-protective, in part, because they result in higher high-density lipoprotein 58 cholesterol (HDL-C) and lower triglyceride (TG) concentrations (2). However, considerable 59
inter-individual variability in response to dietary fat and carbohydrate exists, and assessments of 60
gene-diet interactions have identified variants in regulators of lipoprotein metabolism that 61 contribute to differential responses (4). 62 63
One such regulator is hepatic lipase, which hydrolyzes triglycerides and phospholipids and 64 provides a ligand-binding function for the uptake of lipoproteins and lipoprotein lipids (22) . 65 Therefore, hepatic lipase (LIPC) is a plausible candidate locus for plasma 33) . The nucleotide substitution that creates the LIPC -514 C/T promoter 67 variant (rs1800588) has been shown to decrease hepatic lipase activity. Hepatic lipase activity 68 is a major determinant of HDL-C concentration, such that higher lipase activity contributes to 69 lower HDL-C (3) concentrations. The LIPC -514 C/T variant's association with lower hepatic 70 lipase activity provides a functional basis for its association with higher HDL-C concentrations 71 (8). However, the variant's inconsistent associations with plasma HDL-C and TG 72 concentrations (19, 25, 32) suggested that other factors, including diet, might modulate its 73 association with lipids. 74
Statistical analysis 166 167
Data were analyzed using SAS (SAS Institute Inc., Cary, NC). Categorical traits were compared 168 using Pearson's chi-square test, except for sex for which Fisher's exact test was used. 169
Continuous variables were compared using analysis of variance (ANOVA). Triglycerides were 170 log-transformed to improve distribution. For the dietary intervention, initial linear mixed effects 171 models included phase, dietary intervention, diet-phase interaction, LIPC rs1800588 genotype, 172 diet-genotype interaction and a random subject effect. Because no carryover effect was detected 173 between diet phases (P=0.89), the diet-phase interaction term was removed from subsequent 174 analyses. We tested for SNP x sex interactions to determine whether sex-stratified analyses of 175 the intervention data was statistically justified. The interaction term was not significant so 176 intervention data were analyzed with both sexes combined. Potential confounders included age, 177 sex, waist, and baseline lipid or pre-OGTT glucose concentration. Interaction analyses were 178 conducted using generalized linear model regressions. 179
180
Analyses were conducted in a BPRHS subset with exclusions similar to those applied in the 181 intervention (BMI≤34, without diabetes). We dichotomized dietary exposures for total fat, 182 PUFA, MUFA and SFA (% total energy) into high and low according the median population 183 intake, and evaluated interactions between diet and LIPC genotype for HDL-C, LDL-C, total 184 cholesterol and TG. Models were adjusted for age, smoking status, alcohol, total energy, waist, 185 physical activity and ancestry. 186
187
Results
188
Cross-over dietary intervention 189
Forty-two participants completed the trial, including one who was subsequently excluded due to 190 unusually high HDL-C (124 mg/dL) concentration, leaving 41 in the analytic sample. A 191 CONSORT chart documents the flow of participants through the intervention trial (Figure 1) The minor allele (T) frequency (MAF) was 40.2%. Nutrient profiles of the two diet interventions 196 confirmed higher fat (total and all types) and lower carbohydrate in the Western diet ( Table 1) . 197
Baseline cardio-metabolic traits measured prior to the dietary intervention did not differ across 198 genotypes. HDL-C concentration was marginally higher with TT genotype (P=0.05; Table 2) . 199
200
We first evaluated the effect of dietary interventions without considering genotype for HDL-C, 201 TG, LDL-C, total cholesterol, and OGTT 2-hour glucose concentrations (Table 3) . With all 202 genotypes combined, consumption of the Western diet was associated with higher post-203 intervention HDL-C, LDL-C, and total cholesterol concentrations, compared to the Hispanic diet 204 (Table 3, TT carriers did not differ by diet. In summary, major allele carriers benefited from the higher fat 215 diet for HDL-C, while minor allele carriers did not. For LDL and total cholesterol, no 216 significant interactions were observed between SNP and diet, but several differences by 217 genotype were observed. In major allele carriers (CC/CT) but not in minor allele carriers, the 218
Western diet was associated with higher LDL-C in Phase 1 (Western: 2.9±0.13; Hispanic: 219 2.5±0.14; P=0.025) and with higher total cholesterol in Phase 1 (Western: 4.9±0.14; Hispanic: 220 4.2±0.14; P=0.001) and Phase 2 (Western: 5.0±0.13; Hispanic: 4.6±0.14; P=0.018). Finally, we 221 evaluated gene-diet interactions for TG. No significant interactions or difference by genotype 222 were observed by diet for TG (P>0.05; not shown). 223
224
We performed similar gene-diet interaction analyses for OGTT 2-hour glucose ( Table 5) . For 225 OGTT 2-hour glucose, a dominant genetic model was used, based on published data for 226 glycemic traits (27). We observed a marginally significant interaction for Phase 1 (P-227 interaction=0.07). In Phase 1, CC participants showed a lower glycemic response on the 228
Hispanic diet (P=0.04), while minor allele carriers (CT/TT) showed no difference. In contrast, 229 CT/TT participants showed a lower glycemic response on the Western diet in Phase 2 (P=0.008). 230
The SNP-diet interaction for OGTT in Phase 2 was not significant. 231
232
Cross-sectional analysis of the BPRHS 233 234 Finally, to extend analyses to a larger Caribbean Hispanic population, we tested LIPC SNP-diet 235 interactions for HDL-C in the BPRHS (Table 6 ). The LIPC rs1800588 MAF was 0.31 and 236 genotypes were consistent with Hardy-Weinberg equilibrium. We limited analyses to a subset 237 matched to the intervention for BMI (≤ 34 kg/m 2 ) and without diabetes, and applied the same 238 recessive genetic model. We dichotomized total dietary fat intake into high and low, based on 239 the median intake (% total energy), and observed no significant interaction. We next evaluated a 240 sex-total fat interaction and observed a significant interaction (P=0.036) for HDL-C. Due to the 241 small number of men in the subset (10 with TT genotype, n=5 men in each fat intake group), 242 subsequent SNP-diet interaction analyses for dichotomized total fat (31%), SFA (9%), PUFA 243 (7%) and MUFA (11%) were conducted only in women (n=269; Table 6 ). Significant 244 interactions for HDL-C were observed only for SFA (P-interaction: 0.036; Table 6 ). Minor allele 245 carriers (TT) had higher HDL-C (P=0.038) with low SFA intake (1.5 ± 0.1 mmol/L) compared to 246 high SFA intake (1.2 ± 0.1 mmol/L). No difference was observed for HDL-C in major allele 247 carriers (CC/CT) by SFA intake. SNP-diet interactions were not observed for other types of fats. 248
249
In addition to HDL-C, we evaluated each type of fat (% total energy) in women without diabetes 250 and BMI ≤34 for TG (Table 6 ). As for HDL-C, we observed a significant interaction term for 251 SFA (P-interaction: 0.005), with CC/CT individuals showing higher TG (P=0.003) with low SFA 252 intake (1.7 (95% CI: 1.5, 1.8) mmol/L) compared to high SFA intake (1.4 (95% CI: 1.1, 1.9) 253 mmol/L). In TT carriers, high SFA was marginally associated with higher TG. Interactions 254 between LIPC genotype and dichotomized intakes of other fats for TG were not significant. 255
Finally, we evaluated each type of fat (% total energy) in women without diabetes and BMI ≤34 256 for total cholesterol and LDL-C (Table 7) . No statistically significant interactions were 257 identified for either of these outcomes. 258
259
Discussion 260
Our investigation of dietary modulation of LIPC -514 C/T and cardio-metabolic traits in a dietary 261 intervention showed differences in dietary responses that depended on genotype. Specifically, 262 while minor allele homozygotes (TT) did not demonstrate a reduction in HDL-C in response to 263 higher fat intake, neither did they show the significant increase observed in major allele carriers 264 (CC+CT). We did not detect a statistically significant gene-diet interaction, but the benefits 265 derived from greater fat intake were limited to specific LIPC genotypes. 266
267
Previous studies provide evidence that this locus responds to dietary fat, although the designs 268 and specific findings of the studies vary, and the mechanisms are not well-understood. Two 269 observational studies, the Framingham Heart Study and Singapore Indians, demonstrated 270 interactions between dietary fat intake and the variant, such that high fat intake was associated 271 with higher HDL-C in major allele carriers, but with lower HDL-C in minor allele carriers 272 (19,25). Two interaction interventions confirmed this apparent sensitivity to dietary fat. One 273 weight loss intervention showed that carriers of the minor (T) allele responded more to an 274 intensive, lower fat (<30% energy) lifestyle intervention than to the usual care (9). In a second 275 weight loss intervention that compared low-fat (20% total energy) and high-fat (40% total 276 energy) diets, a difference in HDL-C by LIPC 514 C/T genotype was observed only in the low-277 fat group (31). In the current study, we expected that minor allele carriers would show lower 278 HDL-C concentrations with the high fat (Western) diet intervention. While there was no 279 statistically significant gene-diet interaction, the high fat diet increased HDL-C concentrations in 280 major allele carriers but not in minor allele homozygotes. Evaluations of LDL-C and total 281 cholesterol were similar to HDL-C, in that the Western diet caused statistically significant 282 changes (increases) in major allele carriers but not minor allele homozygotes. Observations for 283 all three lipids are consistent with previous evidence that higher fat diets do not benefit LIPC 284 minor allele carriers. 285
286
The lack of a significant SNP-diet interaction for HDL-C in the current intervention could be 287 related to insufficient statistical power, and could also be related to obesity-related 288 complications, especially insulin resistance. Insulin increases hepatic lipase activity, and greater 289 lipase activity reduces 20, 26) . LIPC -514 C/T is associated with lower lipase 290 activity and higher HDL-C, and the variant also interferes with insulin regulation of the lipase (3, 291 10). The combination of genetically determined loss of insulin-responsiveness and obesity-292 related insulin resistance may obscure the detection of gene-diet interactions. Both a previous 293 study (in which visceral obesity masked the association of LIPC 514 C/T with HDL-C)(24) and 294 the current study support this hypothesis. Among intervention participants at baseline, the mean 295 BMI in TT carriers approached obesity (BMI=29.3 kg/m 2 ) with waist circumference in the 296 abdominally obese range (21). Obesity, which is often associated with lower HDL-C 297 concentrations, may have prevented the genotype association with HDL-C from reaching 298 statistical significance. Similarly, adiposity may have impaired the detection of SNP-diet 299 interactions, by modulating HDL-C across all genotype categories. 300
301
Detection of SNP-diet interactions for OGTT could also have been obscured by insulin 302 resistance. For OGTT, there was a marginally significant interaction between LIPC genotype 303 and diet only for Phase 1, in which the glucose concentration was higher with the Western diet 304 compared to the Hispanic diet in CC individuals. There are several possible explanations for the 305 lack of interaction in Phase 2. First, we had some evidence that participants were more compliant 306 to the diet during Phase 1 than Phase 2, which would maximize differences between the diets, to 307 improve interaction detection. Second, the baseline diet for most participants was probably 308 closer to the Western diet than the Hispanic diet (data not shown). For those whose Phase 1 diet 309 represented a shift from Western to Hispanic, genetically based-differences in response to diet 310 may have been more detectable, and these differences could have driven the marginal interaction 311 seen in Phase 1. By Phase 2, when individuals were shifting from one intervention diet to the 312 other, reduced compliance could have reduced actual differences between the diets, impairing 313 our ability to detect interactions. However, these explanations remain speculative, particularly 314 since no carryover effect was detected between diet phases. 315
316
Findings from the current intervention study and the BPRHS differed to some extent, and these 317 differences could be related to design and sample size. Specifically, in the BPRHS the 318 interactions between dietary fat and the SNP for HDL-C were consistent with earlier interaction 319 analyses in FHS and Singapore Indians. In all three populations, high fat intake was detrimental 320
for HDL-C concentration in minor allele carriers. In the dietary intervention, the interaction term 321
for SNP x dietary pattern did not reach significance, but the higher fat (Western) diet was 322 beneficial for HDL-C only in major allele carriers. One possibility is that large populations are 323 needed to detect statistically significant gene-diet interactions, to minimize the impact of 324 heterogeneity in individual responses. In addition, the dietary patterns differed not only in total15 fat, but also in fat composition (e.g., greater monounsaturated fatty acids in the Hispanic diet), 326 which could also alter responses. 327 328 Intervention findings are strengthened by partial validation in the BPRHS, but limitations exist. 329
Our confirmation of the LIPC SNP x diet interaction in the BPRHS and failure to reach 330 interaction significance in the dietary intervention are likely related to insufficient statistical 331 power in the intervention. The small number of TT individuals (n=8, all women) and few men 332 (n=8) in the intervention precluded our ability to formally conduct sex-specific analyses, which 333 is highly relevant to HDL-C. In addition, heterogeneity in the degree of insulin resistance among 334 participants may have masked detection of gene-diet interactions. Although we excluded 335 diabetes and severe obesity from both studies, the prevalence of metabolic syndrome rose 336 between 2002 (the year of the Framingham LIPC study and 2011 (current intervention 337 completion). This decline in US metabolic health, especially in susceptible ethnic minorities 338 such as Hispanics, may impede the detection of gene-diet interactions (7, 23) . 339
340
In summary, findings from our gene-diet intervention supported but did not entirely confirm 341 interaction patterns established in previous observational studies. Understanding of these 342 inconsistencies is limited, but the differences are not surprising given the considerable variability 343 in outcomes related to this locus. The current study illustrates the complexities and limitations 344 of studying gene-diet interactions using different designs and at different historical time points. 345
Future studies might be improved through more stringent control of variability in phenotypes 346 that influence outcomes, and may require larger sample sizes. In spite of the challenges specific 347
to LIPC, as well as those of gene-diet interactions overall, this study reinforces the need to 348 
